United Therapeutics (UTHR) FCF Margin (2016 - 2025)
Historic FCF Margin for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 43.98%.
- United Therapeutics' FCF Margin rose 38300.0% to 43.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.05%, marking a year-over-year increase of 51300.0%. This contributed to the annual value of 37.55% for FY2024, which is 54300.0% up from last year.
- As of Q3 2025, United Therapeutics' FCF Margin stood at 43.98%, which was up 38300.0% from 16.22% recorded in Q2 2025.
- In the past 5 years, United Therapeutics' FCF Margin registered a high of 7200.0% during Q4 2023, and its lowest value of 3221.52% during Q4 2024.
- Its 5-year average for FCF Margin is 240.82%, with a median of 36.5% in 2021.
- In the last 5 years, United Therapeutics' FCF Margin surged by 71819500bps in 2023 and then crashed by -104215200bps in 2024.
- Quarter analysis of 5 years shows United Therapeutics' FCF Margin stood at 25.05% in 2021, then fell by -28bps to 18.05% in 2022, then soared by 39796bps to 7200.0% in 2023, then crashed by -145bps to 3221.52% in 2024, then skyrocketed by 101bps to 43.98% in 2025.
- Its FCF Margin was 43.98% in Q3 2025, compared to 16.22% in Q2 2025 and 48.63% in Q1 2025.